2Edward J. Antal Ph.D.,Thaddeus H. Grasela Pharm.D.,Larry Ereshefsky Pharm.D.,Barbara G. Wells Pharm.D.,R. Evans Pharm.D.,Randall B. Smith Ph.D.. A multi-center study to evaluate the pharmacokinetic and clinical interactions between alprazolam and imipramine[J] 1991,Journal of Pharmacokinetics and Biopharmaceutics(3):93S～100S
3David A. Graves,Keith T. Muir,Winston Richards,Barry W. Steiger,Ih Chang,Bababhai Patel. Hydralazine dose-response curve analysis[J] 1990,Journal of Pharmacokinetics and Biopharmaceutics(4):279～291
二级参考文献2
1曾衍霖.临床药代动力学中群体及个体参数的估算[J]中国临床药理学杂志,1986(01).
2S. Vozeh,G. Katz,V. Steiner,F. Follath. Population pharmacokinetic parameters in patients treated with oral mexiletine[J] 1982,European Journal of Clinical Pharmacology(5):445～451
